Exagen (XGN) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Exagen Revenue Highlights


Latest Revenue (Y)

$52.55M

Latest Revenue (Q)

$15.06M

Main Segment (Y)

Shipping and Handling

Exagen Revenue by Period


Exagen Revenue by Year

DateRevenueChange
2023-12-31$52.55M15.33%
2022-12-31$45.56M-5.66%
2021-12-31$48.30M15.07%
2020-12-31$41.98M3.93%
2019-12-31$40.39M24.50%
2018-12-31$32.44M21.01%
2017-12-31$26.81M49.38%
2015-12-31$17.95M53.87%
2014-12-31$11.66M281.77%
2013-12-31$3.06M229.91%
2012-12-31$926.00K-

Exagen generated $52.55M in revenue during NA 2023, up 15.33% compared to the previous quarter, and up 161.99% compared to the same period a year ago.

Exagen Revenue by Quarter

DateRevenueChange
2024-06-30$15.06M4.50%
2024-03-31$14.41M4.72%
2023-12-31$13.77M2.60%
2023-09-30$13.42M-5.10%
2023-06-30$14.14M25.89%
2023-03-31$11.23M-12.52%
2022-12-31$12.84M-12.83%
2022-09-30$14.73M64.32%
2022-06-30$8.96M-13.78%
2022-03-31$10.39M-18.09%
2021-12-31$12.69M3.58%
2021-09-30$12.25M-4.08%
2021-06-30$12.77M20.64%
2021-03-31$10.59M-16.43%
2020-12-31$12.67M17.57%
2020-09-30$10.78M20.42%
2020-06-30$8.95M-6.64%
2020-03-31$9.58M-6.17%
2019-12-31$10.21M-2.16%
2019-09-30$10.44M-0.33%
2019-06-30$10.47M13.11%
2019-03-31$9.26M-3.95%
2018-12-31$9.64M17.24%
2018-09-30$8.22M5.68%
2018-06-30$7.78M14.51%
2018-03-31$6.79M52.73%
2015-12-31$4.45M-4.53%
2015-09-30$4.66M4.27%
2015-06-30$4.47M2.31%
2015-03-31$4.37M3.07%
2014-12-31$4.24M15.41%
2014-09-30$3.67M55.79%
2014-06-30$2.36M68.84%
2014-03-31$1.40M27.72%
2013-12-31$1.09M16.90%
2013-09-30$935.00K-

Exagen generated $15.06M in revenue during Q2 2024, up 4.50% compared to the previous quarter, and up 134.14% compared to the same period a year ago.

Exagen Revenue Breakdown


Exagen Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Shipping and Handling$2.50M$2.70M$2.10M$1.40M$1.40M

Exagen's latest annual revenue breakdown by segment (product or service), as of Dec 23: Shipping and Handling (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Shipping and Handling$900.00K$800.00K$600.00K$600.00K$600.00K$700.00K$600.00K$700.00K$700.00K$600.00K$500.00K$600.00K$600.00K$500.00K$300.00K$400.00K$300.00K$400.00K$300.00K$400.00K

Exagen's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Shipping and Handling (100.00%).

Exagen Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
SHCSotera Health$1.05B$276.59M
GTHGenetron$650.71M$201.32M
BNRBurning Rock Biotech$537.43M$125.62M
LMDXLumiraDx$254.48M$21.00M
CSTLCastle Biosciences$219.79M$87.00M
OLKOlink AB (publ)$169.91M$28.59M
FONRFONAR$98.65M$25.72M
XGNExagen$52.55M$15.06M
BDSXBiodesix$49.09M$14.82M
PMDPsychemedics$22.10M$5.36M
DRIODarioHealth$20.35M$6.25M
SERASera Prognostics$306.00K-

XGN Revenue FAQ


Exagen's yearly revenue for 2023 was $52.55M, representing an increase of 15.33% compared to 2022. The company's yearly revenue for 2022 was $45.56M, representing a decrease of -5.66% compared to 2021. XGN's yearly revenue for 2021 was $48.3M, representing an increase of 15.07% compared to 2020.

Exagen's quarterly revenue for Q2 2024 was $15.06M, a 4.50% increase from the previous quarter (Q1 2024), and a 6.56% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $14.42M, a 4.72% increase from the previous quarter (Q4 2023), and a 28.36% increase year-over-year (Q1 2023). XGN's quarterly revenue for Q4 2023 was $13.76M, a 2.60% increase from the previous quarter (Q3 2023), and a 7.23% increase year-over-year (Q4 2022).

Exagen's revenue growth rate for the last 3 years (2021-2023) was 8.80%, and for the last 5 years (2019-2023) was 30.11%.

Exagen's revenue streams in c 23 are Shipping and Handling

For the fiscal year ending Dec 23, the largest source of revenue of Exagen was Shipping and Handling. This segment made a revenue of $2.5M, representing 100.00% of the company's total revenue.